diarylquinoline antibiotic [Drug Class]

Accession ARO:3004491
DefinitionA class of antibiotics used to treat specifically Mycobacterium tuberculosis infection; therefore, referred to as an antimycobacterial. Diarylquinoline antibiotics inhibit ATP synthesis in tuberculosis cells by disruption of mycobacterial ATP synthase.
Classification1 ontology terms | Show
Parent Term(s)1 ontology terms | Show
Sub-Term(s)
4 ontology terms | Show
+ bedaquiline [Antibiotic]
+ antibiotic resistant ATP synthase [AMR Gene Family] confers_resistance_to_drug_class
+ bedaquiline resistant Rv0678 [AMR Gene Family] confers_resistance_to_drug_class
+ bedaquiline resistant Rv2535c [AMR Gene Family] confers_resistance_to_drug_class
Publications

Deoghare S, et al. . Indian J Pharmacol 45(5):536-7 Bedaquiline: a new drug approved for treatment of multidrug-resistant tuberculosis. (PMID 24130398)